The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

42 articles for SW Kaldor


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy.EBI
Eli Lilly
Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease.EBI
Agouron Pharmaceuticals
Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV.EBI
Takeda California
 
Structure-based drug design of nonpeptidic P2 substituents for HIV-1 protease inhibitorsEBI
TBA
 
Isophthalic acid derivatives: amino acid surrogates for the inhibition of HIV-1 proteaseEBI
TBA
 
A systematic study of P1–P3 spanning sidechains for the inhibition of HIV-1 proteaseEBI
TBA
 
Glutamine-derived aldehydes for the inhibition of human rhinovirus 3C proteaseEBI
TBA
 
New dipeptide isosteres useful for the inhibition of HIV-1 proteaseEBI
TBA
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations.EBI
Kinnate Biopharma
The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition.EBI
Kinnate Biopharma
Azetidinones as vasopressin V1a antagonists.EBI
Lehigh University
Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1).EBI
Fount Therapeutics
Expedited discovery of second generation NK-1 antagonists: identification of a nonbasic aryloxy substituent.EBI
Eli Lilly
Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors.EBI
Celgene Quanticel Research
BRD4 inhibitor compound in solid form and preparation method therefor and use thereofBDB
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetaseBDB
Oxford Drug Design
Substituted pyridines as PARP1 inhibitorsBDB
Xinthera
Inhibitors of VAP-1BDB
Acucela
JAK kinase inhibitor compounds for treatment of respiratory diseaseBDB
Theravance Biopharma R&D Ip
Pharmaceutical compoundsBDB
Sareum
Therapeutically active compounds and their methods of useBDB
Servier Pharmaceuticals
Glucagon-like peptide1 receptor agonistsBDB
Eli Lilly
Solid forms of a plasma kallikrein inhibitor and salts thereofBDB
Kalvista Pharmaceuticals
Anti-inflammatory compound, and preparation and use thereofBDB
E-Nitiate Biopharmaceuticals (Hangzhou)
Dihydroquinolinones for medical treatmentBDB
C4 Therapeutics
Inhibitors of RAF kinasesBDB
Kinnate Biopharma
RIP1 inhibitory compounds and methods for making and using the sameBDB
Rigel Pharmaceuticals
Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitorsBDB
Bayer Aktiengesellschaft
Pharmaceutical compoundsBDB
Almac Discovery
Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulatorsBDB
Janssen Pharmaceutica
Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonistsBDB
Nimbus Saturn
Thiazole derivative and applicationsBDB
East China University of Science and Technology
Dihydroxybenzamide compound having HSP90 inhibitory activity or pharmaceutically acceptable salt thereof, and medical use thereofBDB
Oncozen
Nitrogen-containing heterocyclic amide compound and pharmaceutical use thereofBDB
Japan Tobacco
Arginase inhibitors as therapeuticsBDB
Mars
Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.BDB
Stony Brook University
Azetidine-substituted quinoxalines as opioid receptor like-1 modulatorsBDB
Purdue Pharma
Reverse Biosynthesis: Generating Combinatorial Pools of Drug Leads from Enzyme-Mediated Fragmentation of Natural Products.BDB
The University of Sydney
Cinnamoyl inhibitors of transglutaminaseBDB
University of Ottawa
Azetidine derivative and antidepressant composition including the sameBDB
Korea Institute of Science and Technology
Spiro-oxindole MDM2 antagonistsBDB
University of Michigan